West Pharma (WST) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to West Pharma (WST) Tops Q2 EPS by 2c

West Announces Second Quarter 2015 Results

July 30, 2015 7:01 AM EDT

EXTON, PA -- (Marketwired) -- 07/30/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter of 2015 and updated financial guidance for the full year 2015.

Executive Summary

Reported sales of $359.7 million declined 2.5% vs. 2014 period. Net sales at constant currency grew by 7.4%. Reported diluted EPS was $0.38. Adjusted diluted EPS was $0.47, excluding a $0.09 charge on executive retirement. EPS comparisons to the prior-year period are adversely impacted by approximately $0.09 of currency effects. Full-year adjusted diluted EPS is anticipated to be between $1.74 and $1.84,... More